Literature DB >> 26161252

4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor.

P Suresh Jayasekara1, Matthew O Barrett2, Christopher B Ball2, Kyle A Brown2, Eszter Kozma1, Stefano Costanzi3, Lucia Squarcialupi1, Ramachandran Balasubramanian1, Hiroshi Maruoka1, Kenneth A Jacobson1.   

Abstract

4-Alkyloxyimino derivatives of pyrimidine nucleotides display high potency as agonists of certain G protein-coupled P2Y receptors (P2YRs). In an effort to functionalize a P2Y6R agonist for fluorescent labeling, we probed two positions (N4 and γ-phosphate of cytidine derivatives) with various functional groups, including alkynes for click chemistry. Functionalization of extended imino substituents at the 4 position of the pyrimidine nucleobase of CDP preserved P2Y6R potency generally better than γ-phosphoester formation in CTP derivatives. Fluorescent Alexa Fluor 488 conjugate 16 activated the human P2Y6R expressed in 1321N1 human astrocytoma cells with an EC50 of 9 nM, and exhibited high selectivity for this receptor over other uridine nucleotide-activated P2Y receptors. Flow cytometry detected specific labeling with 16 to P2Y6R-expressing but not to wild-type 1321N1 cells. Additionally, confocal microscopy indicated both internalized 16 (t1/2 of 18 min) and surface-bound fluorescence. Known P2Y6R ligands inhibited labeling. Theoretical docking of 16 to a homology model of the P2Y6R predicted electrostatic interactions between the fluorophore and extracellular portion of TM3. Thus, we have identified the N4-benzyloxy group as a structurally permissive site for synthesis of functionalized congeners leading to high affinity molecular probes for studying the P2Y6R.

Entities:  

Year:  2013        PMID: 26161252      PMCID: PMC4493932          DOI: 10.1039/C3MD00132F

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  39 in total

1.  Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.

Authors:  Hiroshi Maruoka; Matthew O Barrett; Hyojin Ko; Dilip K Tosh; Artem Melman; Lauren E Burianek; Ramachandran Balasubramanian; Barkin Berk; Stefano Costanzi; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

2.  Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor.

Authors:  Rosa V Flores; Melvin G Hernández-Pérez; Edna Aquino; Richard C Garrad; Gary A Weisman; Fernando A Gonzalez
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

3.  Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference.

Authors:  Stefano Costanzi; Bhalchandra V Joshi; Savitri Maddileti; Liaman Mamedova; Maria J Gonzalez-Moa; Victor E Marquez; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

4.  Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation.

Authors:  Liaman K Mamedova; Ruibo Wang; Pedro Besada; Bruce T Liang; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2008-08-30       Impact factor: 7.658

5.  Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. SER-333 and SER-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor.

Authors:  A E Brinson; T K Harden
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

6.  Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor.

Authors:  Francesca Deflorian; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2011-04-03       Impact factor: 3.686

7.  Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.

Authors:  Ali El-Tayeb; Aidong Qi; Christa E Müller
Journal:  J Med Chem       Date:  2006-11-30       Impact factor: 7.446

8.  P2Y6 receptor contributes to neutrophil recruitment to inflamed intestinal mucosa by increasing CXC chemokine ligand 8 expression in an AP-1-dependent manner in epithelial cells.

Authors:  Djordje M Grbic; Émilie Degagné; Jean-François Larrivée; Maude S Bilodeau; Valérie Vinette; Guillaume Arguin; Jana Stankova; Fernand-Pierre Gendron
Journal:  Inflamm Bowel Dis       Date:  2011-11-17       Impact factor: 5.325

9.  Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.

Authors:  Stefano Costanzi; Liaman Mamedova; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2004-10-21       Impact factor: 7.446

Review 10.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

Authors:  Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-04-30       Impact factor: 4.774

View more
  7 in total

1.  Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y₁₄ receptor.

Authors:  Evgeny Kiselev; Ramachandran Balasubramanian; Elisa Uliassi; Kyle A Brown; Kevin Trujillo; Vsevolod Katritch; Eva Hammes; Raymond C Stevens; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2015-08-10       Impact factor: 2.823

2.  Pyrimidine Nucleotides Containing a (S)-Methanocarba Ring as P2Y6 Receptor Agonists.

Authors:  Kiran S Toti; Shanu Jain; Antonella Ciancetta; Ramachandran Balasubramanian; Saibal Chakraborty; Ryan Surujdin; Zhen-Dan Shi; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2017-09-06       Impact factor: 3.597

Review 3.  Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands.

Authors:  Francisco Ciruela; Víctor Fernández-Dueñas; Kenneth A Jacobson
Journal:  Neuropharmacology       Date:  2015-04-16       Impact factor: 5.250

Review 4.  John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Silvia Paoletta; Evgeny Kiselev; Saibal Chakraborty; P Suresh Jayasekara; Ramachandran Balasubramanian; Dilip K Tosh
Journal:  Comput Struct Biotechnol J       Date:  2014-10-16       Impact factor: 7.271

5.  4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors.

Authors:  P Suresh Jayasekara; Matthew O Barrett; Christopher B Ball; Kyle A Brown; Eva Hammes; Ramachandran Balasubramanian; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2014-04-18       Impact factor: 7.446

6.  Exploring a 2-naphthoic acid template for the structure-based design of P2Y14 receptor antagonist molecular probes.

Authors:  Evgeny Kiselev; Matthew O Barrett; Vsevolod Katritch; Silvia Paoletta; Clarissa D Weitzer; Kyle A Brown; Eva Hammes; Andrew L Yin; Qiang Zhao; Raymond C Stevens; T Kendall Harden; Kenneth A Jacobson
Journal:  ACS Chem Biol       Date:  2014-10-20       Impact factor: 5.100

7.  Crystal structures of the A2A adenosine receptor and their use in medicinal chemistry.

Authors:  Kenneth A Jacobson
Journal:  In Silico Pharmacol       Date:  2013-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.